Cargando…
Increased dopamine and its receptor dopamine receptor D1 promote tumor growth in human hepatocellular carcinoma
BACKGROUND: Dopamine and dopamine receptor D1 (DRD1), a member of the dopamine receptor family, have been indicated to play important roles in cancer progression, but dopamine secretion in hepatocellular carcinoma (HCC) and the effects of DRD1 on HCC remain unclear. This study was designed to explor...
Autores principales: | Yan, Yan, Pan, Jiahao, Chen, Yonghua, Xing, Wei, Li, Qiang, Wang, Dongyin, Zhou, Xiaoshuang, Xie, Jingdun, Miao, Changhong, Yuan, Yunfei, Zeng, Weian, Chen, Dongtai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7743025/ https://www.ncbi.nlm.nih.gov/pubmed/33017522 http://dx.doi.org/10.1002/cac2.12103 |
Ejemplares similares
-
Dopamine receptor D3 is related to prognosis in human hepatocellular carcinoma and inhibits tumor growth
por: Yan, Yan, et al.
Publicado: (2022) -
The nociceptin receptor promotes autophagy through NF-kB signaling and is transcriptionally regulated by E2F1 in HCC
por: Zhou, Xiaoshuang, et al.
Publicado: (2022) -
Amide-type local anesthetics may suppress tumor cell proliferation and sensitize Human Hepatocellular Carcinoma Cells to Cisplatin via upregulation of RASSF1A expression and demethylation
por: Chen, Dongtai, et al.
Publicado: (2020) -
Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients
por: Chen, Dongtai, et al.
Publicado: (2017) -
Comprehensive Analysis to Identify the Encoded Gens of Sodium Channels as a Prognostic Biomarker in Hepatocellular Carcinoma
por: Yan, Yan, et al.
Publicado: (2022)